Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R F Schell

Showing results (131-140 of 135) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 135 results.
Infection and Immunity|June 13, 2001
Interleukin-6 enhances production of anti-OspC immunoglobulin G2b borreliacidal antibodyM C Remington, E L Munson, S M Callister, et al.
Infection and Immunity|January 20, 2000
Occurrence of severe destructive lyme arthritis in hamsters vaccinated with outer surface protein A and challenged with Borrelia burgdorferiC L Croke, E L Munson, S D Lovrich, et al.
The American Journal of Medicine|July 1, 1984
Cefmenoxime. Clinical, bacteriologic, and pharmacologic studiesJ L LeFrock, A Molavi, R V McCloskey, et al.
Infection and Immunity|July 1, 1994
Development of destructive arthritis in vaccinated hamsters challenged with Borrelia burgdorferiL C Lim, D M England, B K DuChateau, et al.
The Journal of Antimicrobial Chemotherapy|November 1, 1982
Comparative study of ceftizoxime and cefamandole in the treatment of bronchopulmonary infectionsJ L LeFrock, A Molavi, A L Lentnek, et al.
Pageof 14

Showing results (131-140 of 135) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 135 results.
Infection and Immunity|June 13, 2001
Interleukin-6 enhances production of anti-OspC immunoglobulin G2b borreliacidal antibodyM C Remington, E L Munson, S M Callister, et al.
Infection and Immunity|January 20, 2000
Occurrence of severe destructive lyme arthritis in hamsters vaccinated with outer surface protein A and challenged with Borrelia burgdorferiC L Croke, E L Munson, S D Lovrich, et al.
The American Journal of Medicine|July 1, 1984
Cefmenoxime. Clinical, bacteriologic, and pharmacologic studiesJ L LeFrock, A Molavi, R V McCloskey, et al.
Infection and Immunity|July 1, 1994
Development of destructive arthritis in vaccinated hamsters challenged with Borrelia burgdorferiL C Lim, D M England, B K DuChateau, et al.
The Journal of Antimicrobial Chemotherapy|November 1, 1982
Comparative study of ceftizoxime and cefamandole in the treatment of bronchopulmonary infectionsJ L LeFrock, A Molavi, A L Lentnek, et al.
Pageof 14